Daily Archives: February 23, 2010

Is Congress the New FDA?

February 23, 2010

Given the dismal track record of the U.S. Senate in the 111th Congress in producing important legislation to improve the lives of Americans, it appears that some of that body's members are looking for new things to do.  In the … Continue reading →

Posted in FDA Image, Safety and Clinical Trials | 3 Comments

Is the Critical Path Initiative in Critical Condition? Is the Advancing Regulatory Science Initiative Replacing the Critical Path?

Does anyone remember the FDA's Critical Path Initiative (CPI)?  Anyone?  Does the FDA even remember the CPI?   The CPI was launched six years ago in 2004 as the "FDA's national strategy for transforming the way that FDA-regulated products are … Continue reading →

Posted in Drug Safety, FDA Policy, Science | Comments Off